Cystatin forms a tetramer through structural rearrangement of domain-swapped dimers prior to amyloidogenesis

J Mol Biol. 2004 Feb 6;336(1):165-78. doi: 10.1016/j.jmb.2003.12.011.

Abstract

The cystatins were the first amyloidogenic proteins to be shown to oligomerize through a 3D domain swapping mechanism. Here we show that, under conditions leading to the formation of amyloid deposits, the domain-swapped dimer of chicken cystatin further oligomerizes to a tetramer, prior to fibrillization. The tetramer has a very similar circular dichroism and fluorescence signature to the folded monomer and dimer structures, but exhibits some loss of dispersion in the 1H-NMR spectrum. 8-Anilino-1-naphthalene sulfonate fluorescence enhancement indicates an increase in the degree of disorder. While the dimerization reaction is bimolecular and most likely limited by the availability of a predominantly unfolded form of the monomer, the tetramerization reaction is first-order. The tetramer is formed slowly (t(1/2)=six days at 85 degrees C), dimeric cystatin is the precursor to tetramer formation, and thus the rate is limited by structural rearrangement within the dimer. Some higher-order oligomerization events parallel tetramer formation while others follow from the tetrameric form. Thus, the tetramer is a transient intermediate within the pathway of large-scale oligomerization.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amyloid / chemistry
  • Amyloid / metabolism*
  • Animals
  • Chickens
  • Cystatins / chemistry*
  • Cystatins / metabolism
  • Dimerization
  • Humans
  • Models, Molecular
  • Molecular Weight
  • Protein Folding
  • Protein Structure, Quaternary*
  • Recombinant Proteins / chemistry
  • Recombinant Proteins / metabolism

Substances

  • Amyloid
  • Cystatins
  • Recombinant Proteins